We are initiating coverage on Sartorius (market cap. of c.€4.8bn and a free float of c.42%) with a “Reduce” recommendation and a target price of €63.1 per share (c.2% downside). Sartorius is one of the top five players in the high growth €5-6bn oligopolistic bioprocessing industry (the top-five players together control >80% of the total market) with a market share of 15-20%. The industry presents robust growth opportunities and is expected to grow at 9-10% pa ove
07 Feb 2017
Initiating coverage on Sartorius.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Initiating coverage on Sartorius.
Sartorius AG (0NIQ:LON) | 13,825 0 0.0% | Mkt Cap: 10,352m
- Published:
07 Feb 2017 -
Author:
Jyoti Prakash -
Pages:
45
We are initiating coverage on Sartorius (market cap. of c.€4.8bn and a free float of c.42%) with a “Reduce” recommendation and a target price of €63.1 per share (c.2% downside). Sartorius is one of the top five players in the high growth €5-6bn oligopolistic bioprocessing industry (the top-five players together control >80% of the total market) with a market share of 15-20%. The industry presents robust growth opportunities and is expected to grow at 9-10% pa ove